General Information of Drug Off-Target (DOT) (ID: OT0CZ85H)

DOT Name Leucine-rich repeat LGI family member 3 (LGI3)
Synonyms LGI1-like protein 4; Leucine-rich glioma-inactivated protein 3
Gene Name LGI3
Related Disease
Advanced cancer ( )
Glioma ( )
Lung cancer ( )
Lung carcinoma ( )
Non-small-cell lung cancer ( )
Vitiligo ( )
Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects ( )
UniProt ID
LGI3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF03736 ; PF13855
Sequence
MAGLRARGGPGPGLLALSALGFCLMLQVSAKRPPKTPPCPPSCSCTRDTAFCVDSKAVPR
NLPSEVISLTLVNAAFSEIQDGAFSHLPLLQFLLLNSNKFTLIGDNAFTGLSHLQYLFIE
NNDIWALSKFTFRGLKSLTHLSLANNNLQTLPRDIFRPLDILNDLDLRGNSLNCDCKVKW
LVEWLAHTNTTVAPIYCASPPRFQEHKVQDLPLREFDCITTDFVLYQTLAFPAVSAEPFL
YSSDLYLALAQPGVSACTILKWDYVERQLRDYDRIPAPSAVHCKPMVVDSQLYVVVAQLF
GGSYIYHWDPNTTRFTRLQDIDPQRVRKPNDLEAFRIDGDWYFAVADSSKAGATSLYRWH
QNGFYSHQALHPWHRDTDLEFVDGEGKPRLIVSSSSQAPVIYQWSRTQKQFVAQGEVTQV
PDAQAVKHFRAGRDSYLCLSRYIGDSKILRWEGTRFSEVQALPSRGSLALQPFLVGGRRY
LALGSDFSFTQIYQWDEGRQKFVRFQELAVQAPRAFCYMPAGDAQLLLAPSFKGQTLVYR
HIVVDLSA
Function May participate in the regulation of neuronal exocytosis.
Tissue Specificity Widely expressed, with highest levels in brain and lung.
Reactome Pathway
LGI-ADAM interactions (R-HSA-5682910 )

Molecular Interaction Atlas (MIA) of This DOT

7 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Altered Expression [1]
Glioma DIS5RPEH Strong Biomarker [2]
Lung cancer DISCM4YA Strong Altered Expression [1]
Lung carcinoma DISTR26C Strong Altered Expression [1]
Non-small-cell lung cancer DIS5Y6R9 Strong Genetic Variation [3]
Vitiligo DISR05SL Strong Altered Expression [4]
Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects DISO0SJ7 Limited Unknown [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Leucine-rich repeat LGI family member 3 (LGI3). [6]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Leucine-rich repeat LGI family member 3 (LGI3). [9]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic trioxide DM61TA4 Approved Arsenic trioxide decreases the expression of Leucine-rich repeat LGI family member 3 (LGI3). [7]
Methotrexate DM2TEOL Approved Methotrexate increases the expression of Leucine-rich repeat LGI family member 3 (LGI3). [8]
------------------------------------------------------------------------------------

References

1 Leucine-rich glioma inactivated 3: Integrative analyses reveal its potential prognostic role in cancer.Mol Med Rep. 2018 Mar;17(3):3993-4002. doi: 10.3892/mmr.2017.8279. Epub 2017 Dec 14.
2 Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma.Onco Targets Ther. 2017 May 24;10:2721-2728. doi: 10.2147/OTT.S138912. eCollection 2017.
3 Leucine rich repeat LGI family member 3: Integrative analyses reveal its prognostic association with non-small cell lung cancer.Oncol Lett. 2019 Sep;18(3):3388-3398. doi: 10.3892/ol.2019.10648. Epub 2019 Jul 22.
4 Leucine-rich glioma inactivated 3: a novel keratinocyte-derived melanogenic cytokine in vitiligo patients.An Bras Dermatol. 2019 Oct 17;94(4):434-441. doi: 10.1590/abd1806-4841.20198250. eCollection 2019.
5 Next Generation Sequencing and Genome-Wide Genotyping Identify the Genetic Causes of Intellectual Disability in Ten Consanguineous Families from Jordan. Tohoku J Exp Med. 2017 Dec;243(4):297-309. doi: 10.1620/tjem.243.297.
6 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
7 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
8 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.